A review of medical and surgical treatment options for androgenetic alopecia

JAMA Facial Plastic Surgery

Volumn 16, Issue 6, 2014, Pages 444-450

  Rousso, Daniel E ^a,b   Kim, Sang W ^a  

^a Rousso Facial Plastic Surgery Clinic   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FINASTERIDE; MINOXIDIL;

ALOPECIA; COMBINATION DRUG THERAPY; FEMALE; HAIR FOLLICLE; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; ORAL DRUG ADMINISTRATION; TOPICAL DRUG ADMINISTRATION; TRANSPLANTATION;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ALOPECIA; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; FEMALE; FINASTERIDE; HAIR FOLLICLE; HUMANS; MALE; MINOXIDIL;

EID: 84911482346     PISSN: 21686076     EISSN: 21686092     Source Type: Journal    
DOI: 10.1001/jamafacial.2014.316     Document Type: Review

References (43)

1. Cash TF. The psychosocial consequences of androgenetic alopecia: a review of the research literature. Br J Dermatol. 1999;141(3):398-405.
2. Alfonso M, Richter-Appelt H, Tosti A, Viera MS, García M. The psychosocial impact of hair loss among men: a multinational European study. Curr Med Res Opin. 2005;21(11):1829-1836.
3. International Society of Hair Restoration Surgery. 2011 Practice Census Results. https://www.ishrs.org/sites/default/files/users/user3/FinalPracticeCensusReport7-11-11.pdf. Accessed July 9, 2014.
4. Adler SC, Rousso D. Evaluation of past and present hair replacement techniques: aesthetic improvement, effectiveness, postoperative pain, and complications. Arch Facial Plast Surg. 1999;1(4):266-271.
5. Bunagan MJK, Banka N, Shapiro J. Hair transplantation update: procedural techniques, innovations, and applications. Dermatol Clin. 2013;31(1):141-153.
6. Banka N, Bunagan MJK, Shapiro J. Pattern hair loss in men: diagnosis and medical treatment. Dermatol Clin. 2013;31(1):129-140.
7. Yip L, Rufaut N, Sinclair R. Role of genetics and sex steroid hormones in male androgenetic alopecia and female pattern hair loss: an update of what we now know. Australas J Dermatol. 2011;52(2):81-88.
8. Jahoda CAB. Cellular and developmental aspects of androgenetic alopecia. Exp Dermatol. 1998;7(5):235-248.
9. Randall VA, Hibberts NA, Hamada K. A comparison of the culture and growth of dermal papilla cells from hair follicles from non-balding and balding (androgenetic alopecia) scalp. Br J Dermatol. 1996;134(3):437-444.
10. Drake L, Hordinsky M, Fiedler V, et al. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. J Am Acad Dermatol. 1999;41(4):550-554.
11. Van Neste D, Fuh V, Sanchez-Pedreno P, et al. Finasteride increases anagen hair in men with androgenetic alopecia. Br J Dermatol. 2000;143(4):804-810.
12. Stough DB, Rao NA, Kaufman KD, Mitchell C. Finasteride improves male pattern hair loss in a randomized study in identical twins. Eur J Dermatol. 2002;12(1):32-37.
13. Kaufman KD, Olsen EA, Whiting D, et al; Finasteride Male Pattern Hair Loss Study Group. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39(4 Pt 1):578-589.
14. Irwig MS, Kolukula S. Persistent sexual side effects of finasteride for male pattern hair loss. J Sex Med. 2011;8(6):1747-1753.
15. http://www.fda.gov/drugs/drugsafety/informationbydrugclass/ucm299754.htm. Accessed April 14, 2014.
16. Carmina E, Lobo RA. Treatment of hyperandrogenic alopecia in women. Fertil Steril. 2003;79(1):91-95.
17. Atanaskova Mesinkovska N, Bergfeld WF. Hair: what is new in diagnosis and management? female pattern hair loss update: diagnosis and treatment. Dermatol Clin. 2013;31(1):119-127.
18. Olsen EA, Weiner MS, Amara IA, DeLong ER. Five-year follow-up of men with androgenetic alopecia treated with topical minoxidil. J Am Acad Dermatol. 1990;22(4):643-646.
19. Kassimir JJ. Use of topical minoxidil as a possible adjunct to hair transplant surgery: a pilot study. J Am Acad Dermatol. 1987;16(3, pt 2):685-687.
20. Olsen EA, Dunlap FE, Funicella T, et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2002;47(3):377-385.
21. Norwood OT. Male pattern baldness: classification and incidence. South Med J. 1975;68(11):1359-1365.
22. Ludwig E. Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol. 1977;97(3):247-254.
23. Sinclair R, Patel M, Dawson TL Jr, et al. Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness. Br J Dermatol. 2011;165(suppl 3):12-18.
24. Bernstein RM, Rassman WR. The logic of follicular unit transplantation. Dermatol Clin. 1999;17(2):277-295.
25. Unger WP. Delineating the "safe" donor area for hair transplanting. Am J Cosmet Surg. 1994;4:239-243.
26. Williams KL Jr. Current practices and controversies in cosmetic hair restoration. Dermatol Surg. 2013;39(5):797-801.
27. Frechet P. Minimal scars for scalp surgery. Dermatol Surg. 2007;33(1):45-55.
28. Gandelman M, Mota AL, Abrahamsohn PA, De Oliveira SF. Light and electron microscopic analysis of controlled injury to follicular unit grafts. Dermatol Surg. 2000;26(1):25-30.
29. Parsley WM, Perez-Meza D. Review of factors affecting the growth and survival of follicular grafts. J Cutan Aesthet Surg. 2010;3(2):69-75.
30. Rose PT. The latest innovations in hair transplantation. Facial Plast Surg. 2011;27(4):366-377.
31. Uebel CO. A new advance in baldness surgery with the platelet derived growth factor. Hair Transplant Forum Int. 2005;15:770-777.
32. Gökrem S, Baser NT, Aslan G. Follicular unit extraction in hair transplantation: personal experience. Ann Plast Surg. 2008;60(2):127-133.
33. Barr L, Barrera A. Use of hair grafting in scar camouflage. Facial Plast Surg Clin North Am. 2011;19(3):559-568.
34. Umar S. Hair transplantation in patients with inadequate head donor supply using nonhead hair: report of 3 cases. Ann Plast Surg. 2011;67(4):332-335.
35. Harris JA. New methodology and instrumentation for follicular unit extraction: lower follicle transection rates and expanded patient candidacy. Dermatol Surg. 2006;32(1):56-61.
36. Onda M, Igawa HH, Inoue K, Tanino R. Novel technique of follicular unit extraction hair transplantation with a powered punching device. Dermatol Surg. 2008;34(12):1683-1688.
37. Unger WP, Unger RH, Wesley CK. Estimating the number of lifetime follicular units: a survey and comments of experienced hair transplant surgeons. Dermatol Surg. 2013;39(5):755-760.
38. Beehner ML. Management of advanced hair loss patterns. Facial Plast Surg Clin North Am. 2013;21(3):385-395.
39. Bernstein RM, Rassman WR. Graft anchoring in hair transplantation. Dermatol Surg. 2006;32(2):198-204.
40. Lam S. Hairline design. In: Lam S, ed. Hair Transplant 360. St Louis, MO: Jaypee Brothers Medical Pub; 2011:chap 50.
41. Ende KH, Kabaker SS. Hair restoration: medical and surgical techniques. In: Flint PW, Haughey BH, Lund VJ, et al, eds. Cummings Otolaryngology Head and Neck Surgery. 5th ed. St Louis, MO: CV Mosby; 2010:chap 26.
42. Bouhanna P. Topical minoxidil used before and after hair transplantation. J Dermatol Surg Oncol. 1989;15(1):50-53.
43. Avram MR, Cole JP, Gandelman M, et al; Roundtable Consensus Meeting of the 9th Annual Meeting of the International Society of Hair Restoration Surgery. The potential role ofminoxidil in the hair transplantation setting. Dermatol Surg. 2002;28(10):894-900.